Advertisement
Advertisement
NVAX
Novavax Inc
8.54
USDSponsored
-0.13
-1.56%
Apr 21, 12:24 UTC -4
Open
NVAX Earnings Reports
Positive Surprise Ratio
NVAX beat 18 of 41 last estimates.
44%
Next Report
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$80.96M
/-$0.23
Implied change from Q4 25 (Revenue/ EPS)
-44.98%
/-309.09%
Implied change from Q1 25 (Revenue/ EPS)
-87.86%
/-107.85%
Novavax Inc earnings per share and revenue
On Jan 12, 2026, NVAX reported earnings of 0.11 USD per share (EPS) for Q4 25, beating the estimate of -0.49 USD, resulting in a 122.15% surprise. Revenue reached 147.14 million, compared to an expected 92.06 million, with a 59.82% difference. The market reacted with a +17.42% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 7 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 80.96 million USD, implying an decrease of -309.09% EPS, and decrease of -44.98% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Apr 08, 2026 For Q1 26
Estimate
-$0.76
Actual
-$0.79
Surprise
-2.68%
NovaBridge Biosciences - ADR
Report Date
Apr 07, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.28
Surprise
-421.58%
KALA BIO, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.46
Actual
-$0.67
Surprise
+54.38%
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
GeoVax Labs, Inc. New
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$6.29
Actual
$0.00
Surprise
+99.92%
FAQ
What were Novavax Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Novavax Inc reported EPS of $0.11, beating estimates by 122.15%, and revenue of $147.14M, 59.82% above expectations.
How did the market react to Novavax Inc's Q4 2025 earnings?
The stock price moved up 17.42%, changed from $9.53 before the earnings release to $11.19 the day after.
When is Novavax Inc expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Novavax Inc's next earnings report?
Based on 7
analysts, Novavax Inc is expected to report EPS of -$0.23 and revenue of $80.96M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement